Identification of functional cytochrome P450 and ferredoxin from Streptomyces sp. EAS-AB2608 by transcriptional analysis and their heterologous expression
- PMID: 33944982
- DOI: 10.1007/s00253-021-11304-z
Identification of functional cytochrome P450 and ferredoxin from Streptomyces sp. EAS-AB2608 by transcriptional analysis and their heterologous expression
Abstract
Bioconversion using microorganisms and their enzymes is an important tool in many industrial fields. The discovery of useful new microbial enzymes contributes to the development of industries utilizing bioprocesses. Streptomyces sp. EAS-AB2608, isolated from a soil sample collected in Japan, can convert the tetrahydrobenzotriazole CPD-1 (a selective positive allosteric modulator of metabotropic glutamate receptor 5) to its hydroxylated form at the C4-(R) position. The current study was performed to identify the genes encoding the enzymes involved in CPD-1 bioconversion and to verify their function. To identify gene products responsible for the conversion of CPD-1, we used RNA sequencing to analyze EAS-AB2608; from its 8333 coding sequences, we selected two genes, one encoding cytochrome P450 (easab2608_00800) and the other encoding ferredoxin (easab2608_00799), as encoding desirable gene products involved in the bioconversion of CPD-1. The validity of this selection was tested by using a heterologous expression approach. A bioconversion assay using genetically engineered Streptomyces avermitilis SUKA24 ∆saverm3882 ∆saverm7246 co-expressing the two selected genes (strain ES_SUKA_63) confirmed that these gene products had hydroxylation activity with respect to CPD-1, indicating that they are responsible for the conversion of CPD-1. Strain ES_SUKA_63 also showed oxidative activity toward other compounds and therefore might be useful not only for bioconversion of CPD-1 but also as a tool for synthesis of drug metabolites and in optimization studies of various pharmaceutical lead compounds. We expect that this approach will be useful for bridging the gap between the latest enzyme optimization technologies and conventional enzyme screening using microorganisms. KEY POINTS: • Genes easab2608_00800 (cyp) and easab2608_00799 (fdx) were selected by RNA-Seq. • Selection validity was evaluated by an engineered S. avermitilis expression system. • Strain ES_SUKA_63 showed oxidative activity toward CPD-1 and other compounds.
Keywords: Actinobacteria; Bioconversion; Heterologous expression; Oxidative reaction; RNA sequencing.
Similar articles
-
Identification and functional analysis of cytochrome P450 complement in Streptomyces virginiae IBL14.BMC Genomics. 2013 Feb 27;14:130. doi: 10.1186/1471-2164-14-130. BMC Genomics. 2013. PMID: 23442312 Free PMC article.
-
Pentalenic acid is a shunt metabolite in the biosynthesis of the pentalenolactone family of metabolites: hydroxylation of 1-deoxypentalenic acid mediated by CYP105D7 (SAV_7469) of Streptomyces avermitilis.J Antibiot (Tokyo). 2011 Jan;64(1):65-71. doi: 10.1038/ja.2010.135. Epub 2010 Nov 17. J Antibiot (Tokyo). 2011. PMID: 21081950 Free PMC article.
-
Enhanced heterologous expression of two Streptomyces griseolus cytochrome P450s and Streptomyces coelicolor ferredoxin reductase as potentially efficient hydroxylation catalysts.Appl Environ Microbiol. 2003 Jan;69(1):373-82. doi: 10.1128/AEM.69.1.373-382.2003. Appl Environ Microbiol. 2003. PMID: 12514018 Free PMC article.
-
Practical application of cytochrome P450.Biol Pharm Bull. 2012;35(6):844-9. doi: 10.1248/bpb.35.844. Biol Pharm Bull. 2012. PMID: 22687473 Review.
-
Bioconversion of vitamin D to its active form by bacterial or mammalian cytochrome P450.Biochim Biophys Acta. 2011 Jan;1814(1):249-56. doi: 10.1016/j.bbapap.2010.07.014. Epub 2010 Jul 27. Biochim Biophys Acta. 2011. PMID: 20654743 Review.
Cited by
-
Recent Advances in Biocatalysis for Drug Synthesis.Biomedicines. 2022 Apr 21;10(5):964. doi: 10.3390/biomedicines10050964. Biomedicines. 2022. PMID: 35625702 Free PMC article. Review.
-
Investigation on Metabolites in Structure and Biosynthesis from the Deep-Sea Sediment-Derived Actinomycete Janibacter sp. SCSIO 52865.Molecules. 2023 Feb 24;28(5):2133. doi: 10.3390/molecules28052133. Molecules. 2023. PMID: 36903380 Free PMC article.
References
-
- Adams JP, Brown MJ, Diaz-Rodriguez A, Lloyd RC, Roiban GD (2019) Biocatalysis: a pharma perspective. Adv Synth Catal 361:2421–2432. https://doi.org/10.1002/adsc.201900424 - DOI
-
- Arai M, Naito A, Okazaki T, Serizawa N, Iwado S (1990) Application of actinomycetes in the production of pravastatin, a novel cholesterol-lowering agent (in Japanese with English abstract). Actinomycetologica 4:95–102. https://doi.org/10.3209/saj.4_95 - DOI
-
- Baldwin SJ, Clarke SE, Chenery RJ (1999) Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone. Br J Clin Pharmacol 48:424–432. https://doi.org/10.1046/j.1365-2125.1999.00030.x - DOI - PubMed - PMC
-
- Barka EA, Vatsa P, Sanchez L, Gaveau-Vaillant N, Jacquard C, Klenk HP, Clément C, Ouhdouch Y, van Wezel GP (2016) Taxonomy, physiology, and natural products of Actinobacteria. Microbiol Mol Biol Rev 80:1–43. https://doi.org/10.1128/MMBR.00019-15 - DOI - PubMed
-
- Burg RW, Miller BM, Baker EE, Birnbaum J, Currie SA, Hartman R, Kong Y, Monaghan RL, Olson G, Putter I, Tunac JB, Wallick H, Stapley EO, Oiwa R, Ōmura S (1979) Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob Agents Chemother 15:361–367. https://doi.org/10.1128/aac.15.3.361 - DOI - PubMed - PMC
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous